Complicated Appendicitis
13
1
1
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
7.7%
1 terminated out of 13 trials
90.0%
+3.5% vs benchmark
46%
6 trials in Phase 3/4
44%
4 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (13)
Fast Track Therapeutic Model in Acute Complicated Appendicitis in Pediatrics
Antibiotic Instillation in Appendicitis
Laparoscopic Antibiotic Lavage to Prevent Intra-abdominal Abscess Formation in Complicated Appendicitis
Per Oral Versus Intravenous Postoperative Antibiotics After Surgery for Complicated Appendicitis.
Antibiotic Duration in Post-appendectomy Abscess
ERAS for Pediatric Acute Appendicitis
Optimal Care of Complicated Appendicitis
New Diagnostic Markers In Dignosis Of Complicated Appendix
Complicated Appendicitis During the COVID-19 Pandemic in Jordan
Efficacy and Safety Study of Eravacycline Compared With Meropenem in Complicated Intra-abdominal Infections
Complicated Appendicitis in COVID-19 Era
Causes of Complicated Appendicitis at Referral Hospital
Safety and Efficacy of Single Daily Dose of Ceftriaxone and Metronidazole for Treatment of Complicated Appendicitis in Children